Page last updated: 2024-10-24

chlorambucil and Maxillary Neoplasms

chlorambucil has been researched along with Maxillary Neoplasms in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Maxillary Neoplasms: Cancer or tumors of the MAXILLA or upper jaw.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacquillat, C1
Szpirglas, H1
Weil, M1
Levy, D1
Crépy, C1
Cernéa, P1
Bernard, J1

Other Studies

1 other study available for chlorambucil and Maxillary Neoplasms

ArticleYear
[Polychemotherapy of cancer. Preliminary study concerning 82 cases, of which 76 are cases of cancer of stomatologic origin].
    La Presse medicale, 1967, May-27, Volume: 75, Issue:26

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Female; Humans;

1967